You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.

Clinical Advances in

NASH

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), relatively unknown conditions just 2 decades ago, are now the most common causes of chronic liver disease worldwide, affecting an estimated 25% of the world's population. The collective epidemic of NAFLD and NASH closely parallels the epidemics of obesity and type 2 diabetes mellitus. As the prevalence of these conditions continues to increase, predictions are that the prevalence of NAFLD and NASH will also increase, creating unprecedented personal, clinical, and economic burdens. Early disease can be managed with modification of risk factors, and with off-label insulin sensitizers and/or antioxidants in some individuals. And while there are no approved drug regimens to treat NASH, the clinical trial pipeline is very active, with several agents in phase 3 trials. This curriculum will emphasize the importance of risk factor detection and early detection, diagnosis, and treatment -- through either regression or preventing progression of disease -- as means to halting the silent but deadly epidemic.

Supported by an independent educational grant from

Intercept Pharmaceuticals, Inc.

CME Activities

Polling Question

Related Resources

Steering Committee

Zobair M. Younossi, MD, MPH

Zobair M. Younossi, MD, MPH

Steering Committee Chair

Chairman
Department of Medicine
Inova Fairfax Medical Campus
Betty and Guy Beatty Center for Integrated Research, Inova Health System
Falls Church, Virginia, United States

Quentin M. Anstee, MSc(Hons), MB BS, PhD, MRCP (UK), FRCP

Quentin M. Anstee, MSc(Hons), MB BS, PhD, MRCP (UK), FRCP

Professor of Experimental Hepatology and Honorary Consultant
Hepatologist
Institute of Cellular Medicine
Newcastle University
Newcastle upon Tyne, United Kingdom

Elisabetta Bugianesi, MD, PhD

Elisabetta Bugianesi, MD, PhD

Professor
Division of Gastroenterology and Hepatology 
Department of Medical Sciences
University of Turin
Turin, Italy

Kris V. Kowdley, MD

Kris V. Kowdley, MD

Director
Liver Institute Northwest
Clinical Professor
Elson S. Floyd College of Medicine
Washington State University
Spokane, Washington, United States

Mary E. Rinella, MD

Mary E. Rinella, MD

Professor of Medicine (Gastroenterology and Hepatology)
Northwestern University, Feinberg School of Medicine
Chicago, Illinois, United States

Vincent Wong, MBChB(Hons), MD, FRCP, FHKCP, FHKAM

Vincent Wong, MBChB(Hons), MD, FRCP, FHKCP, FHKAM

Professor
Department of Medicine and Therapeutics
The Chinese University of Hong Kong
Hong Kong